Загрузка...
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
BACKGROUND: Dysregulation of N-methyl D-aspartate (NMDA) receptor signaling is strongly implicated in schizophrenia. Based on the ketamine model of NMDA receptor hypoactivity, therapeutic approaches designed to maintain a sustained increase in agonist activity at the glycine site of the NMDA recepto...
Сохранить в:
| Опубликовано в: : | Curr Neuropharmacol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bentham Science Publishers
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327448/ https://ncbi.nlm.nih.gov/pubmed/26915421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666160225154812 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|